Complement C3: a molecular mosaic of binding sites
- PMID: 1829504
- DOI: 10.1016/0161-5890(91)90169-k
Complement C3: a molecular mosaic of binding sites
Abstract
Many of the biological activities of the complement system are mediated by C3, the third complement component, and its proteolytic fragments. At the same time, several of the molecules which regulate complement activation target their action at the C3 molecule. Accordingly, the C3 molecule is equipped with multiple binding sites for at least 14 other complement or complement-related proteins. As described in this review, major progress has been made recently in the identification of the C3 binding sites and the residues involved. Yet this has exposed only the "tip of the iceberg". A novel technique which may facilitate the elucidation of the active sites in C3 is presented. Finally, based on the current knowledge on the C3 molecule, a hypothetical model of the molecular organization of this molecule and its binding sites is presented.
Similar articles
-
Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.J Exp Med. 1983 Aug 1;158(2):334-52. doi: 10.1084/jem.158.2.334. J Exp Med. 1983. PMID: 6224880 Free PMC article.
-
Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.Biochemistry. 1992 Feb 18;31(6):1787-94. doi: 10.1021/bi00121a029. Biochemistry. 1992. PMID: 1371073
-
A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.J Biol Chem. 1988 Aug 25;263(24):12147-50. J Biol Chem. 1988. PMID: 2969896
-
C3b inactivator and beta 1H.Methods Enzymol. 1981;80 Pt C:112-24. Methods Enzymol. 1981. PMID: 6210825 Review. No abstract available.
-
Activation of the alternative complement pathway.CRC Crit Rev Immunol. 1979 Nov;1(1):1-32. CRC Crit Rev Immunol. 1979. PMID: 162484 Review. No abstract available.
Cited by
-
Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia.Mol Med. 2008 Mar-Apr;14(3-4):89-97. doi: 10.2119/2007-00093.Owuor. Mol Med. 2008. PMID: 18317566 Free PMC article.
-
Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity.Cancer Immunol Immunother. 1994 Feb;38(2):119-26. doi: 10.1007/BF01526207. Cancer Immunol Immunother. 1994. PMID: 8306367 Free PMC article. Clinical Trial.
-
Oncolytic measles virus strains have significant antitumor activity against glioma stem cells.Gene Ther. 2013 Apr;20(4):444-9. doi: 10.1038/gt.2012.62. Epub 2012 Aug 23. Gene Ther. 2013. PMID: 22914495 Free PMC article.
-
The effects of dietary supplementation of ginseng stem and leaf saponins on the antioxidant capacity, immune response, and disease resistance of crucian carp, Carassius auratus.Fish Physiol Biochem. 2024 Oct;50(5):1915-1930. doi: 10.1007/s10695-022-01142-9. Epub 2022 Nov 22. Fish Physiol Biochem. 2024. PMID: 36414818
-
An Immunoreceptor-Targeting Strategy with Minimalistic C3b Peptide Fusion Enhances SARS-CoV-2 RBD mRNA Vaccine Immunogenicity.Int J Nanomedicine. 2024 Jul 17;19:7201-7214. doi: 10.2147/IJN.S463546. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39050877 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous